Published • loading... • Updated
Sanofi Breaks Ground on New Insulin Facility
Summary by pharmatimes.com
13 Articles
13 Articles
Zeit Online+3 Reposted by 3 other sources
·Germany
Read Full Article
Frankfurt am Main – The pharmaceutical company Sanofi has started the construction of a new insulin plant in Frankfurt am Main, for which the company, headquartered in Paris, is investing around two billion euros. The new plant is intended to replace an existing insulin plant, which makes provision for people with diabetes in Germany and Europe crisis-proof...
noz.de+5 Reposted by 5 other sources
The pharmaceutical company is setting up a new production facility for insulin in Frankfurt. This is important for diabetics and important far beyond the site. It is about supply issues in Europe.
·Osnabrück, Germany
Read Full Article
Recently, drug manufacturers Eli Lilly and Boehringer Ingelheim had cut investments in Germany. Now there is hope again.
·Düsseldorf, Germany
Read Full ArticleCoverage Details
Total News Sources13
Leaning Left1Leaning Right1Center2Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 25%
C 50%
R 25%
Factuality
To view factuality data please Upgrade to Premium
